Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3751 - 3775 of 6046 in total
Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261646 1752.976103 C82H148N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261647 1781.007403 C84H152N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261648 1809.038703 C86H156N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261650 1807.023053 C86H154N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261649 1837.070003 C88H160N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261651 1835.054353 C88H158N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • type IV B antigen
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type IV B antigen(d18:1/16:0)
44260244 1696.913503 C78H140N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type IV B antigen(d18:1/18:0)
44260245 1724.944803 C80H144N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type IV B antigen(d18:1/20:0)
44260246 1752.976103 C82H148N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type IV B antigen(d18:1/22:0)
44260247 1781.007403 C84H152N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type IV B antigen(d18:1/24:0)
44260248 1809.038703 C86H156N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • type IV B antigen(d18:1/24:1(15Z))
44260250 1807.023053 C86H154N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type IV B antigen(d18:1/26:0)
44260249 1837.070003 C88H160N2O37
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • type IV B antigen(d18:1/26:1(17Z))
44260251 1835.054353 C88H158N2O37
Gangliosides LMSP0601CY00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer
GSG1298
Gangliosides LMSP0601CY01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262556 1825.956097 C83H147N3O40
Gangliosides LMSP0601CY02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262557 1853.987397 C85H151N3O40
Gangliosides LMSP0601CY03
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262558 1882.018697 C87H155N3O40
Gangliosides LMSP0601CY04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262559 1910.049997 C89H159N3O40
Gangliosides LMSP0601CY05
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262560 1938.081297 C91H163N3O40
Gangliosides LMSP0601CY07
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262562 1936.065647 C91H161N3O40
Gangliosides LMSP0601CY06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262561 1966.112597 C93H167N3O40
Gangliosides LMSP0601CY08
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262563 1964.096947 C93H165N3O40
Gangliosides LMSP0601CM00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024